SecBot SecBot
SECBOTREPLAY Home › Report › TSHA

TSHA · Nagendran Sukumar, an officer of Taysha Gene Therapies, filed a Form…

Taysha Gene Therapies, Inc. · 144 filed Apr 10, 2026 at 16:11 ET

At the news

NEUTRALIMPACT 3/10

144 filed Apr 10, 2026 at 16:11 ET

Nagendran Sukumar, an officer of Taysha Gene Therapies, filed a Form 144 to notify intent to sell up to 200,000 shares of common stock, valued at approximately $942,740, under a 10b5-1 selling plan adopted on June 11, 2025. The sale is scheduled for January 12, 2026.

  • Reporting person: Nagendran Sukumar, officer of TSHA
  • Number of shares proposed for sale: 200,000
  • Approximate value of shares: $942,740
  • Sale date: January 12, 2026

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access